@article{mbs:/content/journal/jgv/10.1099/0022-1317-47-2-293, author = "Hruby, D. E. and Lynn, D. L. and Kates, J. R.", title = "Identification of a Virus-specified Protein in the Nucleus of Vaccinia Virus-infected Cells", journal= "Journal of General Virology", year = "1980", volume = "47", number = "2", pages = "293-299", doi = "https://doi.org/10.1099/0022-1317-47-2-293", url = "https://www.microbiologyresearch.org/content/journal/jgv/10.1099/0022-1317-47-2-293", publisher = "Microbiology Society", issn = "1465-2099", type = "Journal Article", abstract = "SUMMARY A new protein has been detected in the nuclei of vaccinia virus-infected cells. This protein has an apparent mol. wt. of 28000 (VP28) on SDS-polyacrylamide gels and has been detected in Triton X-100-treated nuclei of infected BSC-40, L-929 and CVC cells. Within the infected cells, VP28 was synthesized maximally at 1 to 2 h p.i. in the cytoplasm and accumulated in the nuclei at 4 to 5 h p.i. The appearance of VP28 was not affected by cytosine arabinoside (25 µg/ml), an inhibitor of virus DNA synthesis, or rifampicin (100 µg/ml), an inhibitor of vaccinia assembly, but was inhibited by irradiation of the infecting virions; thus classifying it as an early vaccinia virus gene product. Nuclear-cytoplasmic mixing experiments suggested that the nuclear location of VP28 was not an artefact of the cell fractionation techniques employed. VP28 did not appear to be phosphorylated.", }